In closing, this study postulates that VTN constitutes a latent prognostic marker and therapeutic target for pancreatic carcinoma, as well as a predictive and potentiating target for the efficacy of anti-PD1 interventions. Here, VTN is linked to exocrine pancreatic carcinoma.